cjc-1295 ipamorelin increases igf-1 increase clinical data cjc-1295 ipamorelin igf-1 increase percentage studies cjc-1295 ipamorelin typical igf-1 increase
Description
SharmaPKumariPSharmaMSharmaRPaliwalASrivastavaSet al
Differences between Conditions The plasma IGF-1 AUC was not significantly different between conditions (p=0.69) (Figure 2)
All human specimens were procured and analyzed after obtaining written informed consent with the approval of the Ethics Committees of Graduate School of Medicine, Kyoto University (G562)
References Chiarugi, A., Dolle, C., Felici, R
An elevated level of this cytokine is a marker of endothelial dysfunction, which leads to the development of atherosclerosis
